Yoshio Tsunezuka

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 626 citations

Interim Analysis, Oncology, Bevacizumab Versus Erlotinib +8

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer

T Kajita, Yoshihiro Ohta, Keitarou Kimura et al. · British Journal of Cancer · 2001 · 165 citations · Full text

MT-MMP, the cell surface activator of proMMP-2 (progelatinase A), is expressed with its substrate in mouse tissue during embryogenesis

Hiroaki Kinoh, Hiroshi Sato, Yoshio Tsunezuka et al. · Journal of Cell Science · 1996 · 159 citations

Immunology, Molecular Biology, Cell Culture +19

Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay.

Yoshio Tsunezuka, Hiroaki Kinoh, Takahisa Takino et al. · PubMed · 1996 · 121 citations

Experimental Metastasis Assay, Pathology, Tumor Cells +17

Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter

Jian Wu, Yasuhiko Ohta, Hiroshi Minato et al. · The Annals of Thoracic Surgery · 2001 · 103 citations

Tumoral Pathology, Nodal Occult Metastasis, Peripheral Lung Adenocarcinoma +9